Home › Trials › NCT07278583
Clinical trial Recruiting at 1 site Observational Ages 18 and up

Heart failure telemonitoring eligibility after program exclusion

Official title: Evaluation of Eligibility Criteria for Heart Failure Telemonitoring : Analysis of CARDIAUVERGNE's Cohort

Run by University Hospital, Clermont-Ferrand · NCT07278583 · Data updated 2026-11-12

This study tests whether patients who stop telemonitoring due to criteria no longer being met have a low risk of worse health outcomes.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment130 (estimated)
SponsorUniversity Hospital, Clermont-Ferrand
Academic / other
Locations1 site (Clermont-Ferrand)
StatusRecruiting
StartedDecember 5, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJuly 30, 2026
Trial IDNCT07278583 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who were enrolled in the CARDIAUVERGNE telemonitoring program between January 1, 2023 and December 31, 2024 and subsequently excluded due to not meeting eligibility criteria.

Probably not a fit

Patients who continue to experience heart failure progression or who develop new criteria indicating risk may not benefit from reduced monitoring.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study analyzes the prognosis of heart failure patients who were enrolled in a hospital-based telemonitoring program and subsequently excluded when they no longer met eligibility criteria. Patients were followed from January 1, 2023 to December 31, 2024, with follow-up assessments at 6 months and 1 year after exclusion. Data are drawn from medical records, including NYHA status, NT-proBNP levels, weight on connected scales, and any subsequent hospitalizations or changes in treatment. The study aims to determine if loss of eligibility correlates with favorable evolution and reduced need for remote monitoring resources. No intervention beyond standard telemonitoring and documentation of exclusions is described.

Why it matters

Potential benefit: If successful, clinicians may safely reduce monitoring for patients who no longer meet criteria, optimizing resource use without compromising outcomes.

How similar studies have gone: Prior telemonitoring programs have shown mixed results; this study addresses eligibility-based discontinuation to clarify safety of stopping remote monitoring.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* adults
* able to read and understand french
* included in CARDIAUVERGNE telemonitoring program from 1st january 2023 to 31st december 2024 such as defined by the french health authorithy criteria (heart failure within 12 months or dyspnea at least NYHA 2 associated with NTproBNP of at least 1000pg/mL) and excluded by medical decision as no longer presenting eligibillity criteria

Exclusion Criteria:

* Patients leaving telemonitoring for other reasons (choice, death, medical reason, relocation, inobservance)

Where it's running

  • CHU Clermont-Ferrand
    Clermont-Ferrand, France     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Heart Failure 1020University Hospital, Clermont-Ferrand 104
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.